These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23332384)

  • 1. Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer.
    Bondiau PY; Courdi A; Bahadoran P; Chamorey E; Queille-Roussel C; Lallement M; Birtwisle-Peyrottes I; Chapellier C; Pacquelet-Cheli S; Ferrero JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1193-9. PubMed ID: 23332384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors.
    Bondiau PY; Bahadoran P; Lallement M; Birtwisle-Peyrottes I; Chapellier C; Chamorey E; Courdi A; Quielle-Roussel C; Thariat J; Ferrero JM
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1041-7. PubMed ID: 19386428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.
    Chen WC; Kim J; Kim E; Silverman P; Overmoyer B; Cooper BW; Anthony S; Shenk R; Leeming R; Hanks SH; Lyons JA
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):14-20. PubMed ID: 21035961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation.
    Rahimi A; Thomas K; Spangler A; Rao R; Leitch M; Wooldridge R; Rivers A; Seiler S; Albuquerque K; Stevenson S; Goudreau S; Garwood D; Haley B; Euhus D; Heinzerling J; Ding C; Gao A; Ahn C; Timmerman R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):196-205.e2. PubMed ID: 28586960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction.
    Dragun AE; Quillo AR; Riley EC; Roberts TL; Hunter AM; Rai SN; Callender GG; Jain D; McMasters KM; Spanos WJ
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e123-8. PubMed ID: 23195779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant induction chemotherapy.
    Schwartz G
    Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moisture deterioration by APBI.
    Tanaka E; Yamazaki H; Yoshida K; Takenaka T; Masuda N; Kotsuma T; Yoshioka Y; Inoue T
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1098-104. PubMed ID: 20932653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors.
    Rouzier R; Mathieu MC; Sideris L; Youmsi E; Rajan R; Garbay JR; André F; Marsiglia H; Spielmann M; Delaloge S
    Cancer; 2004 Sep; 101(5):918-25. PubMed ID: 15329898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy.
    Gerlach B; Audretsch W; Gogolin F; Königshausen T; Rohn R; Schmitt G; Dimmerling P; Gripp S; Hartmann KA
    Strahlenther Onkol; 2003 May; 179(5):306-11. PubMed ID: 12740657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.